Skip to main content

Oregon State Flag An official website of the State of Oregon »

Oregon.gov Homepage

Notice of Proposed Rules for Public Comment



The public comment period ends Feb. 12 @ 1pm.  Please read all drafts in their entirety and email your comments to naturopathic.medicine@obnm.oregon.gov.  The Board will discuss all comments received on all of the draft rules at the public board meeting at / about 1pm on Feb. 12.  Meeting details will be posted on the Board website approximately one week prior to the meeting.

Email Sent 1/12 - HIGH IMPORTANCE:  SEVERAL DRAFT RULES SUBMITTED FOR PUBLIC COMMENT INCL CHANGES TO THE CE APPROVAL PROCESS - PUBLIC COMMENT PERIOD ENDS 2/12 @1PM 

Email Sent 1/24 - PROPOSED CONTINUING EDUCATION RULES: Clarifications and Projected/Positive Impact on Licensees. Public Comment Open to Feb 12

Email Sent 2/8 - OBNM CORRECTIONS AND CLARIFICATIONS to AANP message to Oregon Licensees:  Changes to CE Rules Will Impact You. Deadline to comment 2/12

CHANGES TO CONTINUING EDUCATION APPROVAL PROCESS: OAR 850-040-0215, 0220 and 0230. 

850.040.0210
Annual Continuing Education Hours for Licensure Renewal

850.040.0215 
Adds approved accreditation services, providers and agencies, limits entities eligible for program approval 

850.040.0220 
Licensee application for continuing education approval, process, and limitations 

850.040.0230 
Criteria for Structured Continuing Education Course Approval, Activities Eligible for Approval, Required Documentation and Limitations 

CLARIFICATION – CE Required for Injection IV Therapy, Provider Requirements, 850-040-0240; Moves One-time CE requirements to Division 40

850.040.0240 
One-time Continuing Education Required Prior to Administering Injection and IV Therapy, and Provider Requirements

DIVISION CHANGE – Moves One-time Continuing Education Required Prior to Administering or Supervising the Administration of IV and Injectable Ketamine, to Division 40,  850-040-0250

850.040.0250 
One-time Continuing Education Required Prior to Administering or Supervising the Administration of IV and Injectable Ketamine